Skip to search.
 TSX Up0.64% TSX Ventures 0.00%

Arena Pharmaceuticals, Inc. (ARNA)

-NMS

7.51 Jun 18, 4:00PM EDT|Pre-Market : 7.75 Up 0.24 (3.20%) 8:15AM EDT - Nasdaq Real Time Price

Add to Portfolio
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period Ending2012-12-302011-12-302010-12-30
Net Income (85,477) (109,224) (124,534)
Operating Activities, Cash Flows Provided By or Used In
Depreciation11,263  16,053  20,883  
Adjustments To Net Income24,804  16,196  13,464  
Changes In Accounts Receivables(5,260)2,878  (1,931)
Changes In Liabilities18,125  (4,512)38,347  
Changes In Inventories(5,875) -   -  
Changes In Other Operating Activities(1,627)352  1,456  
Total Cash Flow From Operating Activities (44,047) (78,257) (52,315)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(1,777)(619)(4,211)
Investments -   -  20,433  
Other Cash flows from Investing Activities(394)(53)95  
Total Cash Flows From Investing Activities (2,171) (672) 16,317  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock167,680  35,639  120,466  
Net Borrowings(23,574)(49,797)(30,717)
Other Cash Flows from Financing Activities -   -   -  
Total Cash Flows From Financing Activities 144,106   (14,158) 89,749  
Effect Of Exchange Rate Changes571  50  2,185  
Change In Cash and Cash Equivalents 98,459   (93,037) 55,936  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.